The short version
Only one company currently supplies this market — there is no backup if it stumbles. The price is down 24% over the past year, to $0.2612 per unit. It is in shortage right now — FDA lists the reason as “demand increase for the drug”. Put together: this is a fragile supply — if anything else goes wrong, there is very little slack to absorb it.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.